Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse

Status Completed

Clinical Trial Summary

The primary purpose of this exploratory and developmental study is to evaluate a mind-body intervention for relapse prevention for women in addiction treatment. The proposed intervention, Mindful Awareness in Body-Oriented Therapy (MABT), is a novel mind-body intervention designed to enhance embodiment and to facilitate mindfulness through the combination of massage, body awareness exercises and the acquisition of mindfulness skills. The treatment goals of MABT include reduction of avoidant coping responses, increase of emotional-regulation, and decrease of trauma symptoms through access to and acceptance (vs. avoidance) of sensory and emotional experience. These are thought to be important for relapse prevention given the positive association between stress, negative affect and relapse; and risk of relapse associated with PTSD symptoms. Mind-body interventions in relapse prevention are of increased clinical and scientific interest, particularly for the potential to overcome automatic response patterns that are associated with lapse and relapse in substance use treatment. This proposal falls within the current NIDA research portfolio focus on the development of interventions that will help people better cope with stress, negative affect, and trauma.

Specific Aims:

- Aim 1: To examine feasibility of recruitment to and retention in MABT as an adjunct to substance abuse treatment. Specifically, to describe a) study enrollment and barriers to recruitment, b) sample characteristics, c) response to randomization, d) session attendance, and e) loss to follow-up.

- Aim 2: To describe MABT acceptability to study participants and substance abuse treatment staff.

- Aim 3: To compare the effect of body-oriented therapy plus treatment-as-usual vs. treatment-as-usual only on reported days abstinent for overall substance use and primary drug use among women receiving substance abuse treatment, in order to estimate the effect size. Secondary analyses will examine for intervention effects on related outcomes including days abstinence on biochemical screens for substance use, body connection indicators, avoidant coping, stress reactivity, co-morbid psychological distress, and physical well-being.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01280916
Study type	Interventional
Source	University of Washington
Contact
Status	Completed
Phase	Phase 1
Start date	October 2008
Completion date	March 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03042832` - Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention	N/A
Completed	`NCT02477280` - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance	Phase 4
Completed	`NCT01693978` - Contingency Outcomes in Prolonged Exposure	N/A
Withdrawn	`NCT05448118` - Virtual MOUD Treatment- Virtual POC Toxicology	N/A
Withdrawn	`NCT05440721` - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification	N/A
Completed	`NCT03694327` - Innovative Digital Therapeutic for Smoking Cessation	N/A
Recruiting	`NCT01979133` - Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders	Phase 3
Completed	`NCT02308878` - Mobile Health Cognitive Stimulation in Heroin Users	N/A
Completed	`NCT01189552` - Depression Treatment for Low Income Substance Users	N/A
Completed	`NCT02964897` - Improving Linkage to Health and Other Services for Veterans Leaving Incarceration	N/A
Not yet recruiting	`NCT06315660` - VR Based Therapy to Treat Anxiety in Dual Diagnosis	N/A
Completed	`NCT02579317` - Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger	N/A
Completed	`NCT01003834` - Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care	N/A
Completed	`NCT03538860` - Validation of an Automated Online Language Interpreting Tool - Phase Two.	N/A
Completed	`NCT02656745` - Clinical Trial of Smoking Cessation Mobile Phone Program	N/A
Active, not recruiting	`NCT03331354` - Assessing the Effect of Distance Learning Vocational Rehabilitation on Employment Outcomes of Veterans With Psychiatric Illness and Histories of Legal Convictions	N/A
Completed	`NCT02110693` - The Tobacco, Alcohol, Prescription Medication and Other Substances Tool	N/A
Not yet recruiting	`NCT06432985` - Smoking Cessation CM for Veterans With or at Risk for Cancer	Phase 2/Phase 3
Not yet recruiting	`NCT05415891` - The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta	N/A
Recruiting	`NCT05344092` - Designing a Mobile App to Support Academic Success for Student Veterans	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms